Brain Cancer & Brain Tumor News Articles |

Brain Cancer News

BRAIN CANCER ADVISOR

Brain Cancer News

FDA Grants Orphan Drug Status to Berubicin for Malignant Gliomas

he designation is supported by data from a phase 1 trial conducted by Reata Pharmaceuticals in 2016. Findings from the study showed 44% of patients treated with berubicin (n=11 out of 25) experienced a statistically significant improvement in progression free survival.